ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

Specialists List 15 Criteria For Choosing Health Insurance.

January 14, 2000

Groups’ Growth, Impact Shown by Five-Year Data

March 3, 1978

Rabson Replaces Berlin At Div. Of Biology, Diagnosis

February 14, 1975

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

RFP Suggestions For Immunodiagnosis Research Offered

October 22, 1976

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011